1887
Volume 2026, Issue 1
  • EISSN: 2220-2749

Abstract

The relationship between clinical indicators and illness severity in hospitalized patients with both diabetes mellitus (DM) and COVID-19 remains incompletely understood, particularly with respect to endocrine markers.

This study aimed to identify clinical predictors of critical illness in hospitalized adults with DM and COVID-19 and to develop a predictive nomogram for individualized risk assessment.

This retrospective cross-sectional study enrolled 393 hospitalized patients with confirmed DM and COVID-19, who were categorized into non-critical ( = 309) and critical ( = 84) groups. We evaluated a comprehensive panel of candidate predictors, including demographic characteristics, vital signs, and laboratory markers such as C-reactive protein (CRP), fasting C-peptide (FCP), and free triiodothyronine (FT3). Multivariable logistic regression was used to develop the prediction model.

Multivariate logistic regression identified several independent predictors of critical illness. Elevated levels of blood urea nitrogen (BUN) (OR: 1.100, 95% CI: 1.026–1.183), serum creatinine (SCr) (OR: 1.027, 95% CI: 1.011–1.043), and CRP (OR: 1.011, 95% CI: 1.005–1.019), along with advanced age (OR: 1.073, 95% CI: 1.039–1.112), were significant risk factors. Conversely, lower levels of FCP (OR: 0.483, 95% CI: 0.305–0.737), FT3 (OR: 0.519, 95% CI: 0.313–0.835), and serum sodium (OR: 0.911, 95% CI: 0.860–0.962) were independent protective factors. The resulting nomogram showed excellent discrimination (C-index = 0.964).

A combination of clinical and laboratory parameters, including age, renal function, inflammatory markers, and endocrine indicators (FCP and FT3), can effectively predict COVID-19 severity in patients with DM. The developed nomogram provides a practical tool for early risk stratification in this high-risk population.

Loading

Article metrics loading...

/content/journals/10.5339/avi.2026.3
2026-03-16
2026-03-17

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/avi/2026/1/avi.2026.3.html?itemId=/content/journals/10.5339/avi.2026.3&mimeType=html&fmt=ahah

References

  1. Li G, Deng Q, Feng J, Li F, Xiong N, He Q, et al.. Clinical characteristics of diabetic patients with COVID-19. J Diabetes Res. 2020 Jul 1620201652403. https://doi.org/10.1155/2020/1652403
    [Google Scholar]
  2. Bell RA, Rigdon J, Bellatorre A, Dabelea D, D’Agostino R, Divers J, et al.. Trends in CVD risk factors for youth with incident diabetes: SEARCH for diabetes in youth. Pediatr Diabetes. 2024 Jul 1120245213520. https://doi.org/10.1155/2024/5213520
    [Google Scholar]
  3. Lei R, Mohan C. Immunological biomarkers of COVID-19. Crit Rev Immunol. 2020 40:(6):497–512. https://doi.org/10.1615/CritRevImmunol.2020035652
    [Google Scholar]
  4. Bhavya , Pathak E, Mishra R. Deciphering the link between diabetes mellitus and SARS-CoV-2 infection through differential targeting of microRNAs in the human pancreas. J Endocrinol Invest. 2022 Mar 45:(3):537–50. https://doi.org/10.1007/s40618-021-01693-3
    [Google Scholar]
  5. Pappa E, Gourna P, Galatas G, Manti M, Romiou A, Panagiotou L, et al.. The prognostic utility of serum thyrotropin in hospitalized Covid-19 patients: Statistical and machine learning approaches. Endocrine. 2023Apr 80:(1):86–92. https://doi.org/10.1007/s12020-022-03264-9
    [Google Scholar]
  6. Wu X, Zhou X, Chen Y, Zhai K, Sun R, Luo G, et al.. The impact of COVID-19 lockdown on cases of and deaths from AIDS, gonorrhea, syphilis, hepatitis B, and hepatitis C: Interrupted time series analysis. JMIR Public Health Surveill. 2023May3; 9:e40591. https://doi.org/10.2196/40591
    [Google Scholar]
  7. Servais T, Laurent F, Roland T, Rossi C, De Groote E, Godart V, et al.. Mortality-related risk factors of inpatients with diabetes and COVID-19: A multicenter retrospective study in Belgium. Ann Endocrinol (Paris). 2024Feb; 85:(1):36–43. https://doi.org/10.1016/j.ando.2023.08.002
    [Google Scholar]
  8. Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al.. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020Mar; 63:(3):364–74. https://doi.org/10.1007/s11427-020-1643-8
    [Google Scholar]
  9. McGurnaghan SJ, Weir A, Bishop J, Kennedy S, Blackbourn LAK, McAllister DA, et al.. Risks of and risk factors for COVID-19 disease in people with diabetes: A cohort study of the total population of Scotland. Lancet Diabetes Endocrinol. 2021Feb; 9:(2):82–93. https://doi.org/10.1016/S2213-8587(20)30405-8
    [Google Scholar]
  10. Bode B, Garrett V, Messler J, McFarland R, Crowe J, Booth R, et al.. Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States. J Diabetes Sci Technol. 2020Jul; 14:(4):813–21. https://doi.org/10.1177/1932296820924469
    [Google Scholar]
  11. Scappaticcio L, Pitoia F, Esposito K, Piccardo A, Trimboli P. Impact of COVID-19 on the thyroid gland: An update. Rev Endocr Metab Disord. 2021Dec; 22:(4):803–15. https://doi.org/10.1007/s11154-020-09615-z
    [Google Scholar]
  12. Lazartigues E, Qadir MMF, Mauvais-Jarvis F. Endocrine significance of SARS-CoV-2’s reliance on ACE2. Endocrinology, 2020Sep1; 161:(9):bqaa108. https://doi.org/10.1210/endocr/bqaa108
    [Google Scholar]
  13. Rotondi M, Coperchini F, Ricci G, Denegri M, Croce L, Ngnitejeu ST, et al.. Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: A clue for COVID-19-related subacute thyroiditis. J Endocrinol Invest. 2021May; 44:(5):1085–90. https://doi.org/10.1007/s40618-020-01436-w
    [Google Scholar]
  14. Chen M, Zhou W, Xu W. Thyroid function analysis in 50 patients with COVID-19: A retrospective study. Thyroid. 2021Jan; 31:(1):8–11. https://doi.org/10.1089/thy.2020.0363
    [Google Scholar]
  15. Gao W, Guo W, Guo Y, Shi M, Dong G, Wang G, et al.. Thyroid hormone concentrations in severely or critically ill patients with COVID-19. J Endocrinol Invest. 2021May; 44:(5):1031–40. https://doi.org/10.1007/s40618-020-01460-w
    [Google Scholar]
  16. Rothberger GD, Valestra PK, Knight K, Desai AK, Calixte R, Shapiro LE. Low free T3 is associated with worse outcomes in patients in the ICU requiring invasive mechanical ventilation. J Intensive Care Med. 2021Mar; 36:(3):313–8. https://doi.org/10.1177/0885066619890822
    [Google Scholar]
  17. Ji N, Zhang M, Ren L, Wang Y, Hu B, Xiang J, et al.. SARS-CoV-2 in the pancreas and the impaired islet function in COVID-19 patients. Emerg Microbes Infect. 2022Dec; 11:(1):1115–25. https://doi.org/10.1080/22221751.2022.2059400
    [Google Scholar]
  18. Chawla A, Sterns RH, Nigwekar SU, Cappuccio JD. Mortality and serum sodium: Do patients die from or with hyponatremia? Clin J Am Soc Nephrol. 2011May; 6:(5):960–5. https://doi.org/10.2215/CJN.10101110
    [Google Scholar]
  19. Khidir RJY, Ibrahim BAY, Adam MHM, Hassan RME, Fedail ASS, Abdulhamid RO, et al.. Prevalence and outcomes of hyponatremia among COVID-19 patients: A systematic review and meta-analysis. Int J Health Sci (Qassim). 2022Sep-Oct; 16(5):69–84. Available from: https://pubmed.ncbi.nlm.nih.gov/36101848/
    [Google Scholar]
  20. Habas E, Ali E, Habas A, Rayani A, Ghazouani H, Khan F, et al.. Hyponatremia and SARS-CoV-2 infection: A narrative review. Medicine (Baltimore). 2022Aug12; 101:(32):e30061. https://doi.org/10.1097/MD.0000000000030061
    [Google Scholar]
/content/journals/10.5339/avi.2026.3
Loading
/content/journals/10.5339/avi.2026.3
Loading

Data & Media loading...

  • Article Type: Research Article
Keyword(s): COVID-19diabetes mellitusnomogramsprognosis and risk factors
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error